eli lilly glp 1 says its experimental GLP-1 pill better than Novo's Rybelsus in diabetes study Lilly says its experimental GLP-1

Intuitively, it would seem that GLP-1 use for obesity would reduce overall medical costs despite the increase in drug spending

Farxiga (Dapagliflozin) is a medication used to treat type 2 diabetes and more

Although rare, associations with nonarteritic anterior ischemic optic neuropathy, pancreatitis, medullary thyroid carcinoma, and acute kidney injury (AKI) have been reported, primarily through pharmacovigilance and case-based evidence

Discover how telehealth is transforming GLP-1 drug marketing, enhancing patient access and reshaping pharmaceutical strategies for type 2 diabetes and obesity.

Manipulated Labels, Word Filters & Bans

Retatrutide, a TRIPLE agonist (GLP1, GIP, glucagon), just released phase 2 trial results demonstrating 25% weight loss in half of people with #obesity